These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38828510)

  • 41. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Wu CJ; Chang HW; Hung WC; Yang CH; Chen YH; Su CY; Yip HK
    Circ J; 2006 Feb; 70(2):163-8. PubMed ID: 16434809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?
    Timóteo AT; Toste A; Ramos R; Miranda F; Ferreira ML; Oliveira JA; Ferreira RC
    Acute Card Care; 2009; 11(4):236-42. PubMed ID: 19742352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multimarker approach with cystatin C, N-terminal pro-brain natriuretic peptide, C-reactive protein and red blood cell distribution width in risk stratification of patients with acute coronary syndromes.
    Vieira C; Nabais S; Ramos V; Braga C; Gaspar A; Azevedo P; Álvares Pereira M; Salomé N; Correia A
    Rev Port Cardiol; 2014 Mar; 33(3):127-36. PubMed ID: 24674467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early changes in N-terminal pro-brain natriuretic peptide levels predict new-onset heart failure in patients with STEMI.
    Del Buono MG; Trankle CR; Buckley L; Kadariya D; Canada JM; Carbone S; Turlington J; Markley R; Bressi E; VAN Tassell BW; Abbate A
    Minerva Cardiol Angiol; 2022 Feb; 70(1):25-31. PubMed ID: 32657561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome.
    Widera C; Pencina MJ; Bobadilla M; Reimann I; Guba-Quint A; Marquardt I; Bethmann K; Korf-Klingebiel M; Kempf T; Lichtinghagen R; Katus HA; Giannitsis E; Wollert KC
    Clin Chem; 2013 Oct; 59(10):1497-505. PubMed ID: 23818444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
    Rørth R; Jhund PS; Kristensen SL; Desai AS; Køber L; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Eur J Heart Fail; 2019 Jan; 21(1):40-49. PubMed ID: 30537261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Comparison of Prognostic Value of the Levels of ProBNP and Troponin T in Patients with Acute Coronary Syndrome (ACS).
    Vogiatzis I; Dapcevic I; Datsios A; Koutsambasopoulos K; Gontopoulos A; Grigoriadis S
    Med Arch; 2016 Jul; 70(4):269-273. PubMed ID: 27703287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes.
    Galvani M; Ottani F; Oltrona L; Ardissino D; Gensini GF; Maggioni AP; Mannucci PM; Mininni N; Prando MD; Tubaro M; Vernocchi A; Vecchio C;
    Circulation; 2004 Jul; 110(2):128-34. PubMed ID: 15197143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure.
    Dai Z; Asano T; Takahashi O; Komiyama N; Ohde S
    BMC Cardiovasc Disord; 2020 Jun; 20(1):262. PubMed ID: 32487160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients.
    García-Salas JM; Tello-Montoliu A; Manzano-Fernández S; Casas-Pina T; López-Cuenca A; Pérez-Berbel P; Puche-Morenilla C; Martínez-Hernández P; Valdés M; Marín F
    Int J Clin Pract; 2014 Mar; 68(3):294-303. PubMed ID: 24372920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.
    Aimo A; Januzzi JL; Mueller C; Mirò O; Pascual Figal DA; Jacob J; Herrero-Puente P; Llorens P; Wussler D; Kozhuharov N; Sabti Z; Breidthardt T; Vergaro G; Ripoli A; Prontera C; Saccaro L; Passino C; Emdin M
    Int J Cardiol; 2019 Oct; 293():137-142. PubMed ID: 31200964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An evidence-based algorithm for the use of B-type natriuretic testing in acute coronary syndromes.
    McCullough PA; Peacock WF; O'Neil B; de Lemos JA; Lepor NE; Berkowitz R
    Rev Cardiovasc Med; 2010; 11 Suppl 2():S51-65. PubMed ID: 20700103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study.
    Sterling MR; Durant RW; Bryan J; Levitan EB; Brown TM; Khodneva Y; Glasser SP; Richman JS; Howard G; Cushman M; Safford MM
    BMC Cardiovasc Disord; 2018 Apr; 18(1):66. PubMed ID: 29661151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
    Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE
    J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography.
    Miglioranza MH; Gargani L; Sant'Anna RT; Rover MM; Martins VM; Mantovani A; Weber C; Moraes MA; Feldman CJ; Kalil RA; Sicari R; Picano E; Leiria TL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1141-51. PubMed ID: 24094830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.